Deutsche Bank AG Buys Shares of 192,197 Teladoc Health, Inc. $TDOC

Key Points

• Deutsche Bank acquired 192,197 Teladoc Health shares worth approximately $1.63 million, giving it a 0.11% stake. Institutional investors and hedge funds collectively own 76.82% of TDOC.
• Teladoc reported a quarterly loss of $0.21 per share, beating estimates for a $0.25 loss, while revenue of $606.93 million fell 4% year over year and missed analysts’ expectations.
• Analyst sentiment remains mixed, with TDOC receiving an average “Hold” rating and a consensus price target of $7.54; recent targets range from $7.50 to $10.50.

Deutsche Bank AG bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 192,197 shares of the health services provider's stock, valued at approximately $1,630,000. Deutsche Bank AG owned about 0.11% of Teladoc Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in TDOC. Monaco Asset Management SAM acquired a new stake in Teladoc Health in the second quarter worth $26,864,000. Jupiter Asset Management Ltd. boosted its holdings in shares of Teladoc Health by 293.9% during the fourth quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider's stock valued at $27,021,000 after acquiring an additional 2,880,008 shares during the period. Quantinno Capital Management LP grew its position in shares of Teladoc Health by 128.0% during the first quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider's stock worth $14,287,000 after acquiring an additional 1,471,631 shares during the last quarter. Pale Fire Capital SE increased its holdings in shares of Teladoc Health by 74.8% in the 1st quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider's stock worth $18,522,000 after acquiring an additional 1,454,288 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Teladoc Health by 23.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,889,194 shares of the health services provider's stock worth $53,260,000 after acquiring an additional 1,325,106 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Teladoc Health

In other news, insider Adam C. Vandervoort sold 7,906 shares of the business's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $60,322.78. Following the transaction, the insider directly owned 110,261 shares in the company, valued at $841,291.43. The trade was a 6.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Charles Divita III sold 19,132 shares of the business's stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $145,977.16. Following the completion of the transaction, the chief executive officer owned 389,894 shares in the company, valued at $2,974,891.22. This trade represents a 4.68% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 39,195 shares of company stock worth $299,058. Corporate insiders own 0.70% of the company's stock.

Teladoc Health Trading Up 2.4%

TDOC stock opened at $6.51 on Friday. Teladoc Health, Inc. has a one year low of $4.40 and a one year high of $9.89. The firm has a 50-day moving average of $7.94 and a two-hundred day moving average of $6.64. The firm has a market capitalization of $1.18 billion, a PE ratio of -6.58 and a beta of 2.12.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.25) by $0.04. The company had revenue of $606.93 million during the quarter, compared to analyst estimates of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The company's revenue for the quarter was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.19) earnings per share. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -0.89 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have issued reports on TDOC. Citigroup reduced their target price on shares of Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research note on Monday, August 3rd. Bank of America boosted their price objective on Teladoc Health from $9.00 to $10.50 and gave the stock a "buy" rating in a research report on Tuesday, July 7th. Weiss Ratings reissued a "sell (d-)" rating on shares of Teladoc Health in a report on Wednesday, August 19th. Finally, Canaccord Genuity Group reduced their price target on Teladoc Health from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, July 30th. Five equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $7.54.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source